Universal Cells Revenue and Competitors

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Universal Cells's estimated annual revenue is currently $12.9M per year.(i)
  • Universal Cells's estimated revenue per employee is $155,000

Employee Data

  • Universal Cells has 83 Employees.(i)
  • Universal Cells grew their employee count by 2% last year.

Universal Cells's People

NameTitleEmail/Phone
1
Associate Director, Research, Gene EditingReveal Email/Phone
2
President, Chief Intelligence and Liaison OfficerReveal Email/Phone
3
Associate DirectorReveal Email/Phone
4
Director Cell Editing and Process DevelopmentReveal Email/Phone
5
Exec Director, Clinical Gene Editing & StrategyReveal Email/Phone
6
Senior Director Core TechnologiesReveal Email/Phone
7
Executive Director, Head R&DReveal Email/Phone
8
Senior Project ManagerReveal Email/Phone
9
Environment, Health and Safety ManagerReveal Email/Phone
10
Manager, Lab OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M60%N/AN/A
#2
$0.9M60%N/AN/A
#3
$5.1M336%N/AN/A
#4
$5.7M3742%N/AN/A
#5
$1.4M18-10%N/AN/A
#6
$3.7M48-21%$16MN/A
#7
$1.1M70%N/AN/A
#8
$0.8M5-81%N/AN/A
#9
$2.5M16-27%N/AN/A
#10
$0.8M5-17%N/AN/A
Add Company

What Is Universal Cells?

Universal Cells Inc. is a private biotechnology company based in Seattle, Washington that is enabling the field of regenerative medicine by creating stem cells that are universally compatible. Our technology is based on intellectual property exclusively in-licensed from the University of Washington and includes methods for genome editing in human stem cells via homologous recombination with recombinant adeno-associated virus (rAAV) vectors, as well as specific HLA-engineering strategies.

keywords:N/A

N/A

Total Funding

83

Number of Employees

$12.9M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Universal Cells News

2022-04-19 - Will we ever get a universal Covid vaccine?

But other parts of the immune system, such as T cells, may persist for years. While not as fast-acting as antibodies, they come in after an...

2022-04-13 - Allogene opens East Bay cell therapy manufacturing center ...

Aiming to make cell therapy universal, biotech opens East Bay ... Allogene Therapeutics Inc.'s 136,000-square-foot cell therapy...

2022-04-06 - Researchers develop universal AI algorithm to "clean" noisy single-cell RNA sequencing data

Cory Brouwer, developed an artificial intelligence algorithm to "clean" noisy single-cell RNA sequencing (scRNA-Seq) data. The study, "A...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$22.4M832%N/A
#2
$26.8M836%N/A
#3
$26.8M83-12%N/A
#4
$12.9M835%N/A
#5
$10M8315%N/A